Locemia Solutions (Intranasal Glucagon in Montreal, Canada) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Latest Deal Amount
  • $149M

Locemia Solutions (Intranasal Glucagon in Montreal, Canada) General Information

Description

A treatment for severe hypoglycemia in people with diabetes treated with insulin. The drug uses a proprietary glucagon nasal powder formulation that is delivered in an emergency situation using a single-use, ready-to-use device.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Montreal, Quebec
  • Canada
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Eli Lilly and Company
Vertical(s)
Life Sciences
Corporate Office
  • Montreal, Quebec
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Locemia Solutions (Intranasal Glucagon in Montreal, Canada) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Corporate Asset Purchase 09-Oct-2015 $149M Completed
To view Locemia Solutions (Intranasal Glucagon in Montreal, Canada)’s complete valuation and funding history, request access »

Locemia Solutions (Intranasal Glucagon in Montreal, Canada) Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Locemia Solutions Corporation Majority
To view Locemia Solutions (Intranasal Glucagon in Montreal, Canada)’s complete investors history, request access »

Ready to get started?

Request a free trial

Locemia Solutions (Intranasal Glucagon in Montreal, Canada) FAQs

  • Where is Locemia Solutions (Intranasal Glucagon in Montreal, Canada) headquartered?

    Locemia Solutions (Intranasal Glucagon in Montreal, Canada) is headquartered in Montreal, Canada.

  • What industry is Locemia Solutions (Intranasal Glucagon in Montreal, Canada) in?

    Locemia Solutions (Intranasal Glucagon in Montreal, Canada)’s primary industry is Buildings and Property.

  • Is Locemia Solutions (Intranasal Glucagon in Montreal, Canada) a private or public company?

    Locemia Solutions (Intranasal Glucagon in Montreal, Canada) is a Private company.

  • What is the current valuation of Locemia Solutions (Intranasal Glucagon in Montreal, Canada)?

    The current valuation of Locemia Solutions (Intranasal Glucagon in Montreal, Canada) is .

  • What is Locemia Solutions (Intranasal Glucagon in Montreal, Canada)’s current revenue?

    The current revenue for Locemia Solutions (Intranasal Glucagon in Montreal, Canada) is .

  • Who are Locemia Solutions (Intranasal Glucagon in Montreal, Canada)’s investors?

    Locemia Solutions has invested in Locemia Solutions (Intranasal Glucagon in Montreal, Canada).

  • When was Locemia Solutions (Intranasal Glucagon in Montreal, Canada) acquired?

    Locemia Solutions (Intranasal Glucagon in Montreal, Canada) was acquired on 09-Oct-2015.

  • Who acquired Locemia Solutions (Intranasal Glucagon in Montreal, Canada)?

    Locemia Solutions (Intranasal Glucagon in Montreal, Canada) was acquired by Eli Lilly and Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »